Here are six additional notes on the report:
1. The $187 million in net sales was made up of $158 million in global spine sales and $29 million in global orthopedic sales.
2. Net sales increased 58.4 percent over the second quarter of 2022.
3. The company’s gross profit increased $33.1 million to reach $119.6 million.
4. Orthofix is predicting 2023 full-year net sales to be between $752 million and $758 million.
5. Net income for the quarter was a loss of $39.4 million compared to a positive net income of $2.5 million in the second quarter of 2022.
6. The company reported a net income of negative $100.4 million through the first two quarters of 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
